414 related articles for article (PubMed ID: 17655530)
1. A triangulation study of the clinician and patient experiences of the use of the immunosuppressant drugs azathioprine and 6-mercaptopurine for the management of inflammatory bowel disease.
Holbrook K
J Clin Nurs; 2007 Aug; 16(8):1427-34. PubMed ID: 17655530
[TBL] [Abstract][Full Text] [Related]
2. Treatment of inflammatory bowel disease with azathioprine and 6-mercaptopurine.
Su C; Lichtenstein GR
Gastroenterol Clin North Am; 2004 Jun; 33(2):209-34, viii. PubMed ID: 15177535
[TBL] [Abstract][Full Text] [Related]
3. Current use of pharmacogenetic testing: a national survey of thiopurine methyltransferase testing prior to azathioprine prescription.
Fargher EA; Tricker K; Newman W; Elliott R; Roberts SA; Shaffer JL; Bruce I; Payne K
J Clin Pharm Ther; 2007 Apr; 32(2):187-95. PubMed ID: 17381669
[TBL] [Abstract][Full Text] [Related]
4. Shared care: a qualitative study of GPs' and hospital doctors' views on prescribing specialist medicines.
Horne R; Mailey E; Frost S; Lea R
Br J Gen Pract; 2001 Mar; 51(464):187-93. PubMed ID: 11255899
[TBL] [Abstract][Full Text] [Related]
5. Review article: monitoring of immunomodulators in inflammatory bowel disease.
Aberra FN; Lichtenstein GR
Aliment Pharmacol Ther; 2005 Feb; 21(4):307-19. PubMed ID: 15709982
[TBL] [Abstract][Full Text] [Related]
6. Epilepsy monitoring and advice recorded: general practitioners' views, current practice and patients' preferences.
Ridsdale L; Robins D; Fitzgerald A; Jeffery S; McGee L
Br J Gen Pract; 1996 Jan; 46(402):11-4. PubMed ID: 8745845
[TBL] [Abstract][Full Text] [Related]
7. Tolerability and safety of mercaptopurine in azathioprine-intolerant patients with inflammatory bowel disease.
Lees CW; Maan AK; Hansoti B; Satsangi J; Arnott ID
Aliment Pharmacol Ther; 2008 Feb; 27(3):220-7. PubMed ID: 17988235
[TBL] [Abstract][Full Text] [Related]
8. Informed consent? How do primary care professionals prepare women for cervical smears: a qualitative study.
Chew-Graham C; Mole E; Evans LJ; Rogers A
Patient Educ Couns; 2006 Jun; 61(3):381-8. PubMed ID: 15964735
[TBL] [Abstract][Full Text] [Related]
9. Experiences of carrying out talking therapy in general practice: a qualitative interview study.
Davidsen A
Patient Educ Couns; 2008 Aug; 72(2):268-75. PubMed ID: 18472244
[TBL] [Abstract][Full Text] [Related]
10. Thiopurine therapy: when to start and when to stop.
McGovern DP; Travis SP
Eur J Gastroenterol Hepatol; 2003 Mar; 15(3):219-23. PubMed ID: 12610314
[TBL] [Abstract][Full Text] [Related]
11. A new role for nurses as Primary Care Cancer Lead Clinicians in Primary Care Trusts in England.
Leese B; Allgar V; Heywood P; Walker R; Darr A; Din I; West RM
J Nurs Manag; 2006 Sep; 14(6):462-71. PubMed ID: 16919124
[TBL] [Abstract][Full Text] [Related]
12. Allopurinol safely and effectively optimizes tioguanine metabolites in inflammatory bowel disease patients not responding to azathioprine and mercaptopurine.
Sparrow MP; Hande SA; Friedman S; Lim WC; Reddy SI; Cao D; Hanauer SB
Aliment Pharmacol Ther; 2005 Sep; 22(5):441-6. PubMed ID: 16128682
[TBL] [Abstract][Full Text] [Related]
13. Monitoring of thiopurine methyltransferase activity in postsurgical patients with Crohn's disease during 1 year of treatment with azathioprine or mesalazine.
Dilger K; Schaeffeler E; Lukas M; Strauch U; Herfarth H; Müller R; Schwab M
Ther Drug Monit; 2007 Feb; 29(1):1-5. PubMed ID: 17304143
[TBL] [Abstract][Full Text] [Related]
14. Immunosuppressive drugs in the treatment of inflammatory bowel disease.
Aranda R; Horgan K
Semin Gastrointest Dis; 1998 Jan; 9(1):2-9. PubMed ID: 9547850
[TBL] [Abstract][Full Text] [Related]
15. Patient care guidelines: a telephone survey of intensive care practices in New South Wales.
Knowles S; Rolls K; Elliott D; Hardy J; Middleton S
Aust Crit Care; 2010 Feb; 23(1):21-9. PubMed ID: 19914086
[TBL] [Abstract][Full Text] [Related]
16. Protocol-based care: impact on roles and service delivery*.
Rycroft-Malone J; Fontenla M; Bick D; Seers K
J Eval Clin Pract; 2008 Oct; 14(5):867-73. PubMed ID: 19018920
[TBL] [Abstract][Full Text] [Related]
17. Thiopurines in inflammatory bowel disease: pharmacogenetics, therapeutic drug monitoring and clinical recommendations.
Al Hadithy AF; de Boer NK; Derijks LJ; Escher JC; Mulder CJ; Brouwers JR
Dig Liver Dis; 2005 Apr; 37(4):282-97. PubMed ID: 15788214
[TBL] [Abstract][Full Text] [Related]
18. [Therapy of chronic inflammatory bowel diseases with azathioprine, 6-mercaptopurine and 6-thioguanine. Clinico-pharmacologic aspects].
Schwab M; Herrlinger K; Schaeffeler E; Stange EF
Dtsch Med Wochenschr; 2003 Feb; 128(8):378-85. PubMed ID: 12594624
[No Abstract] [Full Text] [Related]
19. Monitoring 6-thioguanine nucleotide concentrations in Japanese patients with inflammatory bowel disease.
Andoh A; Tsujikawa T; Ban H; Hashimoto T; Bamba S; Ogawa A; Sasaki M; Saito Y; Fujiyama Y
J Gastroenterol Hepatol; 2008 Sep; 23(9):1373-7. PubMed ID: 18662197
[TBL] [Abstract][Full Text] [Related]
20. Monitoring of long-term thiopurine therapy among adults with inflammatory bowel disease.
Hindorf U; Lyrenäs E; Nilsson A; Schmiegelow K
Scand J Gastroenterol; 2004 Nov; 39(11):1105-12. PubMed ID: 15545169
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
